SCHEMBL23869366

SCHEMBL23869366

N#Cc1cccc(-c2cc(-n3c4ccc(-c5ccccc5)cc4c4cc(-c5ccccc5)ccc43)ncc2-n2c3ccc(-c4ccccc4)cc3c3cc(-c4ccccc4)ccc32)c1C#N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.41
HIF1A Q16665 1/20 0.41
SSTR2 P30874 1/20 0.34
GABRG2 P18507 5/20 0.34
GABRB3 P28472 5/20 0.34
ALDH1A1 P00352 3/20 0.34
GABRA5 P31644 3/20 0.34
GABRA3 P34903 3/20 0.34
NPSR1 Q6W5P4 2/20 0.34
TDP1 Q9NUW8 1/20 0.34
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
FLT3 P36888 1/20 0.33
NR3C1 P04150 1/20 0.33
GABRA1 P14867 4/20 0.32
GABRA2 P47869 4/20 0.32
CYP1A2 P05177 2/20 0.32
CYP3A4 P08684 2/20 0.32
HSD17B10 Q99714 2/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23869353 0.97 SMN1; SMN2 (0.39) SMN1; SMN2HIF1ASSTR2GABRG2GABRB3
SCHEMBL21928999 0.91 GABRG2 (0.39) GABRG2GABRB3ALDH1A1GABRA5GABRA3
SCHEMBL23855961 0.91 NR3C1 (0.34) SMN1; SMN2HIF1AALDH1A1NR3C1CYP1A2
SCHEMBL23855891 0.90 SMN1; SMN2 (0.33) SMN1; SMN2HIF1AALDH1A1CYP1A2CYP3A4
SCHEMBL21929062 0.88 ALDH1A1 (0.37) SSTR2GABRG2GABRB3ALDH1A1GABRA5
SCHEMBL23869346 0.88 SMN1; SMN2 (0.37) SMN1; SMN2HIF1AGABRG2GABRB3ALDH1A1
SCHEMBL23855865 0.87 ALDH1A1 (0.39) SMN1; SMN2ALDH1A1NPSR1TDP1CYP11B1
SCHEMBL21928630 0.85 GRIN1 (0.41) HIF1AGABRG2GABRB3ALDH1A1GABRA5
SCHEMBL23868874 0.85 PTGDR2 (0.36) SMN1; SMN2HIF1AGABRG2GABRB3ALDH1A1
SCHEMBL21928644 0.85 CYP1A2 (0.36) GABRG2GABRB3ALDH1A1GABRA5GABRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12029116-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2024-07-02 US disclosed
US-12029116-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2024-07-02 US disclosed
US-20210305517-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX, INC. (JP) 2021-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12029116-B2 Composition of matter for use in organic light-emitting diodes OPRD1, DRD1, DRD3 SMN1; SMN2 3726/4885HIF1A 4659/4885SSTR2 2910/4885
US-20210305517-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES OPRD1, DRD1, DRD3 SMN1; SMN2 3726/4885HIF1A 4659/4885SSTR2 2910/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.